Cargando…

Analytical Performance Validation of Next-Generation Sequencing Based Clinical Microbiology Assays Using a K-mer Analysis Workflow

Next-generation sequencing (NGS) enables clinical microbiology assays such as molecular typing of bacterial isolates which is now routinely applied for infection control and epidemiology. Additionally, feasibility for NGS-based identification of antimicrobial resistance (AMR) markers as well as gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Lepuschitz, Sarah, Weinmaier, Thomas, Mrazek, Katharina, Beisken, Stephan, Weinberger, Johannes, Posch, Andreas E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422695/
https://www.ncbi.nlm.nih.gov/pubmed/32849463
http://dx.doi.org/10.3389/fmicb.2020.01883
_version_ 1783570051467575296
author Lepuschitz, Sarah
Weinmaier, Thomas
Mrazek, Katharina
Beisken, Stephan
Weinberger, Johannes
Posch, Andreas E.
author_facet Lepuschitz, Sarah
Weinmaier, Thomas
Mrazek, Katharina
Beisken, Stephan
Weinberger, Johannes
Posch, Andreas E.
author_sort Lepuschitz, Sarah
collection PubMed
description Next-generation sequencing (NGS) enables clinical microbiology assays such as molecular typing of bacterial isolates which is now routinely applied for infection control and epidemiology. Additionally, feasibility for NGS-based identification of antimicrobial resistance (AMR) markers as well as genetic prediction of antibiotic susceptibility testing results has been demonstrated. Various bioinformatics approaches enabling NGS-based clinical microbiology assays exist, but standardized, computationally efficient and scalable sample-to-results workflows including validated quality control parameters are still lacking. Bioinformatics analysis workflows based on k-mers have been shown to allow for fast and efficient analysis of large genomics data sets as obtained from microbial sequencing applications. We here demonstrate applicability of k-mer based clinical microbiology assays for whole-genome sequencing (WGS) including variant calling, taxonomic identification, bacterial typing as well as AMR marker detection. The wet-lab and dry-lab workflows were developed and validated in line with Clinical Laboratory Improvement Act (CLIA) guidelines for laboratory-developed tests (LDTs) on multi-drug resistant ESKAPE pathogens. The developed k-mer based workflow demonstrated ≥99.39% repeatability, ≥99.09% reproducibility and ≥99.76% accuracy for variant calling and applied assays as determined by intra-day and inter-day triplicate measurements. The limit of detection (LOD) across assays was found to be at 20× sequencing depth and 15× for AMR marker detection. Thorough benchmarking of the k-mer based workflow revealed analytical performance criteria are comparable to state-of-the-art alignment based workflows across clinical microbiology assays. Diagnostic sensitivity and specificity for multilocus sequence typing (MLST) and phylogenetic analysis were 100% for both approaches. For AMR marker detection, sensitivity and specificity were 95.29 and 99.78% for the k-mer based workflow as compared to 95.17 and 99.77% for the alignment-based approach. Summarizing, results illustrate that k-mer based analysis workflows enable a broad range of clinical microbiology assays, potentially not only for WGS-based typing and AMR gene detection but also genetic prediction of antibiotic susceptibility testing results.
format Online
Article
Text
id pubmed-7422695
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74226952020-08-25 Analytical Performance Validation of Next-Generation Sequencing Based Clinical Microbiology Assays Using a K-mer Analysis Workflow Lepuschitz, Sarah Weinmaier, Thomas Mrazek, Katharina Beisken, Stephan Weinberger, Johannes Posch, Andreas E. Front Microbiol Microbiology Next-generation sequencing (NGS) enables clinical microbiology assays such as molecular typing of bacterial isolates which is now routinely applied for infection control and epidemiology. Additionally, feasibility for NGS-based identification of antimicrobial resistance (AMR) markers as well as genetic prediction of antibiotic susceptibility testing results has been demonstrated. Various bioinformatics approaches enabling NGS-based clinical microbiology assays exist, but standardized, computationally efficient and scalable sample-to-results workflows including validated quality control parameters are still lacking. Bioinformatics analysis workflows based on k-mers have been shown to allow for fast and efficient analysis of large genomics data sets as obtained from microbial sequencing applications. We here demonstrate applicability of k-mer based clinical microbiology assays for whole-genome sequencing (WGS) including variant calling, taxonomic identification, bacterial typing as well as AMR marker detection. The wet-lab and dry-lab workflows were developed and validated in line with Clinical Laboratory Improvement Act (CLIA) guidelines for laboratory-developed tests (LDTs) on multi-drug resistant ESKAPE pathogens. The developed k-mer based workflow demonstrated ≥99.39% repeatability, ≥99.09% reproducibility and ≥99.76% accuracy for variant calling and applied assays as determined by intra-day and inter-day triplicate measurements. The limit of detection (LOD) across assays was found to be at 20× sequencing depth and 15× for AMR marker detection. Thorough benchmarking of the k-mer based workflow revealed analytical performance criteria are comparable to state-of-the-art alignment based workflows across clinical microbiology assays. Diagnostic sensitivity and specificity for multilocus sequence typing (MLST) and phylogenetic analysis were 100% for both approaches. For AMR marker detection, sensitivity and specificity were 95.29 and 99.78% for the k-mer based workflow as compared to 95.17 and 99.77% for the alignment-based approach. Summarizing, results illustrate that k-mer based analysis workflows enable a broad range of clinical microbiology assays, potentially not only for WGS-based typing and AMR gene detection but also genetic prediction of antibiotic susceptibility testing results. Frontiers Media S.A. 2020-08-05 /pmc/articles/PMC7422695/ /pubmed/32849463 http://dx.doi.org/10.3389/fmicb.2020.01883 Text en Copyright © 2020 Lepuschitz, Weinmaier, Mrazek, Beisken, Weinberger and Posch. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Lepuschitz, Sarah
Weinmaier, Thomas
Mrazek, Katharina
Beisken, Stephan
Weinberger, Johannes
Posch, Andreas E.
Analytical Performance Validation of Next-Generation Sequencing Based Clinical Microbiology Assays Using a K-mer Analysis Workflow
title Analytical Performance Validation of Next-Generation Sequencing Based Clinical Microbiology Assays Using a K-mer Analysis Workflow
title_full Analytical Performance Validation of Next-Generation Sequencing Based Clinical Microbiology Assays Using a K-mer Analysis Workflow
title_fullStr Analytical Performance Validation of Next-Generation Sequencing Based Clinical Microbiology Assays Using a K-mer Analysis Workflow
title_full_unstemmed Analytical Performance Validation of Next-Generation Sequencing Based Clinical Microbiology Assays Using a K-mer Analysis Workflow
title_short Analytical Performance Validation of Next-Generation Sequencing Based Clinical Microbiology Assays Using a K-mer Analysis Workflow
title_sort analytical performance validation of next-generation sequencing based clinical microbiology assays using a k-mer analysis workflow
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422695/
https://www.ncbi.nlm.nih.gov/pubmed/32849463
http://dx.doi.org/10.3389/fmicb.2020.01883
work_keys_str_mv AT lepuschitzsarah analyticalperformancevalidationofnextgenerationsequencingbasedclinicalmicrobiologyassaysusingakmeranalysisworkflow
AT weinmaierthomas analyticalperformancevalidationofnextgenerationsequencingbasedclinicalmicrobiologyassaysusingakmeranalysisworkflow
AT mrazekkatharina analyticalperformancevalidationofnextgenerationsequencingbasedclinicalmicrobiologyassaysusingakmeranalysisworkflow
AT beiskenstephan analyticalperformancevalidationofnextgenerationsequencingbasedclinicalmicrobiologyassaysusingakmeranalysisworkflow
AT weinbergerjohannes analyticalperformancevalidationofnextgenerationsequencingbasedclinicalmicrobiologyassaysusingakmeranalysisworkflow
AT poschandrease analyticalperformancevalidationofnextgenerationsequencingbasedclinicalmicrobiologyassaysusingakmeranalysisworkflow